Tumour volume decreased, and the survival time of tumour-bearing mice was prolonged significantly following the injection of CD40-mediated inflammatory E-cadherin+ DCs compared with injection of E-cadherin− DCs. This evidence concerns the gene CDH1 and neoplasm.